搜尋結果
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 7 小時前The Food and Drug Administration on Friday expanded the approval of GSK's respiratory ...
Health Care Roundup: Market Talk
The Wall Street Journal· 13 小時前Find insights on Biomea Fusion, Eli Lilly, Bayer, and more in the latest Market Talks covering ...
Lessons From Australia Can Help Global Shark Attack Strategies
Forbes· 1 日前Shark attacks (which will be referred to as ‘shark-human interactions’ throughout this article) ...
Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer
Forbes· 1 日前A four-week course of dual immunotherapy prior to surgery is highly effective in treating a ...
遠大醫藥(00512)核藥板塊頻傳捷報,創新產品全球研發推進凸顯產業優勢,前瞻性佈局夯實核藥領軍地位
阿思達克財經網· 2 日前智通財經APP訊,近日,港股科技創新型醫藥企業遠大醫藥(00512)核藥板塊傳來多項利好消息,公司順利舉辦了核...
How Being An Introvert Can Grow Your Career
Forbes· 2 日前Too often, introverts in the business world sell themselves short, assuming they’re not ...
Council Post: Revolutionizing Wellness: The Future Of Tech In Massage Therapy
Forbes· 2 日前As the demand for massage equipment continues to grow to nearly $16 billion by 2032, new ...
Focus: Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Reuters· 2 日前Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market ...
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic
Reuters· 2 日前At least 11 generic versions of Novo Nordisk's popular diabetes drug Ozempic are in the ...
Beijing hospital promotes clinical trial awareness and participation
China Daily· 2 日前"Accelerating the high-quality development of clinical trials and advancing pharmaceutical R&D and innovation act as important ...